Nicox and Glaukos Sign Exclusive NCX 1728 Research and Global Licensing Option Agreement
Option entitles Glaukos to exclusive global license agreements on pre-agreed terms including upfront and milestone payments plus royalties Glaukos to fund and conduct NCX 1728 preclinical research activities evaluating it in glaucoma (including …